Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00612001What this trial is testingVaccine Therapy in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center 8
Early research (Phase 1)Study completedNCT00004892What this trial is testingO6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00354068What this trial is testingImatinib Mesylate and Temozolomide in Treating Patients With Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Duke University 65
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT00788125What this trial is testingDasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more City of Hope Medical Center 7
Early research (Phase 1)Study completedNCT00008086What this trial is testingCalcitriol Plus Carboplatin in Treating Patients With Advanced Solid TumorsWho this might be right forBrain and Central Nervous System TumorsUnspecified Adult Solid Tumor, Protocol Specific University of Pittsburgh
Testing effectiveness (Phase 2)Study completedNCT00004024What this trial is testingBiological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or OligodendrogliomaWho this might be right forBrain and Central Nervous System Tumors Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT00002754What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain TumorsWho this might be right forBrain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer Duke University 6
Testing effectiveness (Phase 2)Study completedNCT00107237What this trial is testingAEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Novartis Pharmaceuticals 16
Testing effectiveness (Phase 2)Study completedNCT00424060What this trial is testingEpothilone ZK-219477 in Treating Patients With Recurrent GlioblastomaWho this might be right forBrain and Central Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 38
Large-scale testing (Phase 3)Study completedNCT00052455What this trial is testingTemozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Institute of Cancer Research, United Kingdom 500
Early research (Phase 1)Study completedNCT00387933What this trial is testingImatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Duke University 37
Early research (Phase 1)Study completedNCT00025558What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain CancerWho this might be right forBrain and Central Nervous System Tumors NYU Langone Health
Early research (Phase 1)Study completedNCT00014521What this trial is testingKarenitecin in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT00021307What this trial is testingTemozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forBrain and Central Nervous System Tumors Fox Chase Cancer Center
Early research (Phase 1)Study completedNCT01975116What this trial is testingP28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System TumorsWho this might be right forTeratoid Tumor, AtypicalChoroid Plexus NeoplasmsAnaplastic Astrocytoma+7 more Pediatric Brain Tumor Consortium 18
Early research (Phase 1)Ended earlyNCT04489420What this trial is testingNatural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBMWho this might be right forAstrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+11 more Celularity Incorporated 3
Testing effectiveness (Phase 2)Study completedNCT01164189What this trial is testingBevacizumab in Recurrent Grade II and III GliomaWho this might be right forCentral Nervous System Tumors European Organisation for Research and Treatment of Cancer - EORTC 155
Testing effectiveness (Phase 2)Ended earlyNCT01836549What this trial is testingImetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic EpendymomaAstrocytoma, Grade II+6 more Pediatric Brain Tumor Consortium 43